TABACCO, GAIA
 Distribuzione geografica
Continente #
AS - Asia 3.539
NA - Nord America 1.300
EU - Europa 637
SA - Sud America 213
Continente sconosciuto - Info sul continente non disponibili 48
AF - Africa 32
OC - Oceania 9
Totale 5.778
Nazione #
SG - Singapore 2.645
US - Stati Uniti d'America 1.238
IT - Italia 340
CN - Cina 330
HK - Hong Kong 252
BR - Brasile 147
VN - Vietnam 75
GB - Regno Unito 73
BD - Bangladesh 67
FR - Francia 53
IN - India 49
DE - Germania 40
IQ - Iraq 27
CA - Canada 25
AR - Argentina 21
NL - Olanda 21
MX - Messico 19
IR - Iran 18
FI - Finlandia 16
TR - Turchia 15
CO - Colombia 14
ES - Italia 14
EC - Ecuador 10
ID - Indonesia 10
RU - Federazione Russa 9
UA - Ucraina 9
PS - Palestinian Territory 8
AU - Australia 7
SE - Svezia 7
VE - Venezuela 7
JP - Giappone 6
PL - Polonia 6
RO - Romania 6
AT - Austria 5
EG - Egitto 5
GR - Grecia 5
LT - Lituania 5
PH - Filippine 5
PK - Pakistan 5
SA - Arabia Saudita 5
SN - Senegal 5
BE - Belgio 4
CL - Cile 4
CZ - Repubblica Ceca 4
JM - Giamaica 4
MA - Marocco 4
MD - Moldavia 4
UG - Uganda 4
UY - Uruguay 4
YE - Yemen 4
ZA - Sudafrica 4
BG - Bulgaria 3
CR - Costa Rica 3
EE - Estonia 3
HR - Croazia 3
LY - Libia 3
PT - Portogallo 3
PY - Paraguay 3
TN - Tunisia 3
ET - Etiopia 2
HN - Honduras 2
KR - Corea 2
NP - Nepal 2
PE - Perù 2
SV - El Salvador 2
TH - Thailandia 2
UZ - Uzbekistan 2
AE - Emirati Arabi Uniti 1
AG - Antigua e Barbuda 1
AL - Albania 1
AZ - Azerbaigian 1
BO - Bolivia 1
BS - Bahamas 1
BY - Bielorussia 1
CH - Svizzera 1
GA - Gabon 1
GT - Guatemala 1
IL - Israele 1
IS - Islanda 1
KW - Kuwait 1
LB - Libano 1
LK - Sri Lanka 1
MG - Madagascar 1
MS - Montserrat 1
NI - Nicaragua 1
NZ - Nuova Zelanda 1
OM - Oman 1
PR - Porto Rico 1
QA - Qatar 1
TJ - Tagikistan 1
TW - Taiwan 1
VG - Isole Vergini Britanniche 1
WS - Samoa 1
XK - ???statistics.table.value.countryCode.XK??? 1
Totale 5.731
Città #
San Jose 321
Ashburn 296
Hong Kong 237
Singapore 206
Rome 180
Dallas 103
Hefei 100
Beijing 89
Council Bluffs 74
Boardman 61
London 56
Columbus 55
Lauterbourg 43
Shanghai 32
Ho Chi Minh City 29
Santa Clara 29
Munich 24
New York 20
Los Angeles 18
San Francisco 13
Turku 13
Chicago 11
Hanoi 11
Boston 10
Milan 10
Rūpnagar 10
Washington 9
Amsterdam 8
Frankfurt am Main 8
Mexico City 8
Nablus 8
São Paulo 8
Atlanta 6
Brooklyn 6
Chennai 6
Genoa 6
Las Vegas 6
Montreal 6
Naples 6
Pune 6
Rio de Janeiro 6
Stockholm 6
Biên Hòa 5
Campinas 5
Caracas 5
Dakar 5
Milton 5
Orem 5
Porto Alegre 5
Seattle 5
Warsaw 5
Baghdad 4
Bogotá 4
Bologna 4
Brasília 4
Brno 4
Canberra 4
Da Nang 4
Haiphong 4
Jakarta 4
Kingston 4
Palermo 4
Quito 4
Sanaa 4
Tokyo 4
Toronto 4
Bari 3
Berlin 3
Bucharest 3
Cagayan de Oro 3
Catania 3
Curitiba 3
Esteio 3
Florence 3
Granada 3
Guayaquil 3
Helsinki 3
Iasi 3
Istanbul 3
Kampala 3
Miami 3
Mumbai 3
New Delhi 3
Philadelphia 3
Phoenix 3
San José 3
St Louis 3
Tehran 3
Thái Bình 3
Adana 2
Agadir 2
Agra 2
Agugliano 2
Aigaleo 2
Alvorada 2
Athens 2
Bangkok 2
Barcelona 2
Barranquilla 2
Belford Roxo 2
Totale 2.356
Nome #
A Novel Interplay Between Irisin and PTH: From Basic Studies to Clinical Evidence in Hyperparathyroidism 264
Calcium Citrate Versus Calcium Carbonate in the Management of Chronic Hypoparathyroidism: A Randomized, Double-Blind, Crossover Clinical Trial 255
Point-of-Care device for measuring Thyroid function regulatory compounds in a biological fluid 241
Bone Quality as Measured by Trabecular Bone Score in Normocalcemic Primary Hyperparathyroidism 227
Calcium citrate: from biochemistry and physiology to clinical applications 226
Bone quality in hypoparathyroidism 224
NOVEL APPROACHES TO EVALUATE BONE QUALITY IN PARATHYROID GLAND DISEASES 211
Changes in Skeletal Microstructure Through Four Continuous Years of rhPTH(1-84) Therapy in Hypoparathyroidism 208
Evaluating the effect of calcifediol supplementation on seizure frequency in people with drug-resistant epilepsy 207
Denosumab discontinuation and the rebound phenomenon: A narrative review 156
CLINICAL, BIOCHEMICAL AND RADIOLOGICAL PROFILE OF NORMOCALCAEMIC HYPERPARATHYROIDISM: A MULTICENTRIC CROSS-SECTIONAL EVALUATION 151
A Rare Complication following Thyroid Percutaneous Ethanol Injection: Plummer Adenoma 137
DXA-Based Bone Strain Index: A New Tool to Evaluate Bone Quality in Primary Hyperparathyroidism 137
Hobnail variant of papillary thyroid carcinoma showing goiter-like presentation and rapid growth 136
Dipeptidyl Peptidase 3 Activity as a Promising Biomarker of Bone Fragility in Postmenopausal Women 136
A Pilot Study of Cognition Among Hypoparathyroid Adults 134
CARDIOVASCULAR AUTONOMIC NEUROPATHY CAUSES AN IMPAIRMENT OF QUALITY OF LIFE IN SUBJECTS WITH CHRONIC HYPOPARATHYROIDISM 132
Bone and diabetes 123
A Rare and Severe Complication Following Thyroid Fine Needle Aspiration: Retropharyngeal Cellulitis 120
Clinical, biochemical, and radiological profile of normocalcemic primary hyperparathyroidism 119
Cardiovascular autonomic neuropathy as a cause of fatigue in chronic hypoparathyroidism 111
Cardiovascular Autonomic Neuropathy as a New Complication of Postsurgical Chronic Hypoparathyroidism 107
DXA-based bone strain index in normocalcemic primary hyperparathyroidism 102
Diagnostic Performance of 4D CT and Sestamibi SPECT/CT in Localizing Parathyroid Adenomas in Primary Hyperparathyroidism 100
Osteoanabolic and dual action drugs 96
Raman Spectroscopy Applied to Parathyroid Tissues: A New Diagnostic Tool to Discriminate Normal Tissue from Adenoma 88
Therapy of Hypoparathyroidism With rhPTH(1-84): A Prospective, 8-Year Investigation of Efficacy and Safety 87
Effect of hydrolyzed infant formula vs conventional formula on risk of type 1 diabetes the TRIGR randomized clinical trial 86
Nodule size as predictive factor of efficacy of radiofrequency ablation in treating autonomously functioning thyroid nodules. 81
Real-Time Evaluation of Thyroid Cytology Using New Digital Microscopy Allows for Sample Adequacy Assessment, Morphological Classification, and Supports Molecular Analysis 73
Leg restlessness and hyperparathyroidism in Parkinson's disease, a further clue to RLS pathogenesis? 73
Two-Step Surgical Strategy for Parathyroid Carcinoma: A Single-Center Experience 71
Quality of Life in Hypoparathyroidism Improves With rhPTH(1-84) Throughout 8 Years of Therapy 70
The impact of antiosteoporotic drugs on glucose metabolism and fracture risk in diabetes: Good or bad news? 70
Irisin as a regulator of bone and glucose metabolism 70
Hypovitaminosis D: Is it time to consider the use of calcifediol? 70
Platelet function and markers of atherothrombotic risk in individuals with parathyroid disorders 70
Long-term efficacy and safety of percutaneous ethanol injection (PEI) in cystic thyroid nodules: A systematic review and meta-analysis 68
PTH(1-34) for surgical hypoparathyroidism: A 2-year prospective, open-label investigation of efficacy and quality of life 65
PTH(1-34) for the primary prevention of postthyroidectomy hypocalcemia: The THYPOS trial 64
Metabolic profile of human parathyroid adenoma 60
Initial Assessment and Monitoring of Patients with Chronic Hypoparathyroidism: A Systematic Current Practice Survey 59
Patients diagnosed with low-risk thyroid cancer during coVid-19 pandemic: what did they ask surgeons? 57
Management of Hypoparathyroidism 56
Irisin as a regulator of bone and glucose metabolism: a narrative review. 56
Regression of papillary thyroid cancer during nivolumab for renal cell cancer 48
Efficacy of radiofrequency and laser thermal ablation in solving thyroid nodule-related symptoms and cosmetic concerns. A systematic review and meta-analysis 47
IRISIN IN POSTMENOPAUSAL WOMEN WITH PRIMARY HYPERPARATHYROIDISM: AN INTERPLAY BETWEEN IRISIN AND PTH 43
Proton Pump Inhibitors and Fractures in Adults: A Critical Appraisal and Review of the Literature 42
PTH and bone material strength in hypoparathyroidism as measured by impact microindentation 41
New Directions in Treatment of Hypoparathyroidism 38
PTH-driven modulation of platelet activity via the NOX2 pathway in postsurgical hypoparathyroidism 35
Anthropometric Indices and Markers of Atherothrombotic Risk in Subjects with Primary Hyperparathyroidism 15
Magnesium as an Endocrine Modulator: Physiological Roles, Clinical Evidence, and Therapeutic Perspectives 11
Site-specific fracture risk in chronic hypoparathyroidism: systematic review and meta-analysis 4
Totale 5.778
Categoria #
all - tutte 28.015
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 28.015


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/202267 0 1 3 0 2 0 0 0 15 0 0 46
2022/202375 2 0 1 1 2 0 5 0 7 6 43 8
2023/2024304 16 19 17 18 40 90 26 27 8 6 13 24
2024/20253.001 52 21 57 42 31 50 32 12 131 232 1.052 1.289
2025/20262.151 163 83 179 203 137 113 552 110 164 219 124 104
2026/2027180 45 135 0 0 0 0 0 0 0 0 0 0
Totale 5.778